BRCA mutation carrying mothers may have different risks depending on whether the mutation is BRCA1 or BRCA2.
©llhedgehogll - stock.adobe.com
Number and timing of pregnancies may affect breast cancer risk in BRCA mutation carriers, according to a new study, but the risks differ depending on whether the mutation is BRCA1 or BRCA2. The findings were published in JNCI Cancer Spectrum.
The study assessed 9,232 women in a retrospective cohort and 3,886 in a prospective cohort. They were aged 18 to 80 years and had a known pathogenic BRCA1or BRCA2 mutation. The authors used weighted and time-varying Cox proportional hazards models to examine reproductive event in the two cohorts.
For BRCA1 carriers, the authors found that in women who had two, three, or four or more full-term pregnancies (FTP), breast cancer risk decreased by 21%, 30% and 50%, respectively. However, compared to being nulliparous, uniparous BRCA1 women were at an increased risk for breast cancer. The authors also found that increasing the duration of breastfeeding led to a reduction in breast cancer risk. Relative to a recent pregnancy, longer time since last full-term pregnancy (FTP) was associated with higher risk.
For BRCA2 carriers, risk of breast cancer did not decrease with multiple pregnancies unless a woman had four or more FTPs (4 vs 1 HR = 0.72, 95% CI 0.54-0.98). Parous BRCA2 carriers with fewer than four FTPs had a 30% increase in breast cancer risk. That risk also increased as age at first FTP increased for this population.
The authors believe that their findings can be helpful to ob/gyns when counseling their patients about family planning. The results can also be beneficial for refining breast cancer risk estimates and improving surveillance of mutation carriers based on their reproductive history.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More